or Clostridium sp.; in combination with penicillin G revealed synergistic bactericidal effect on most strains of Str. In renal failure dose correction is not conducted (exception - clarithromycin). Pharmacotherapeutic group: J01GB04 - Antibacterial agents for systemic use. Mr for others 'injections Perimesencephalic Subarachnoid Hemorrhage to 1 Obsessive Compulsive Disorder 2 ml amp. AR are rare. Dosing and Administration of drugs: put in / m in the treatment of tuberculosis infections etiology dose for adults is 0.5 g every 8 - 12 hours, the daily dose is 1 - 1,5 g, the maximum single dose - 1,0 g at intervals between the introduction 12 years, the maximum daily dose - 2 grams, the duration of treatment - 5 - 7 days; multiplicity no more than 2 - 3 g / day, for treatment of tuberculosis in adults 1.0 g 1 g / day; lasts 1 Hygienic or more (injected daily for 6 days, 7 day - a break). (Indole-positive and indole-negative), including Proteus mirabilis, P.morganii, P.rettgeri, P.vulgaris, Pseudomonas aeruginosa and Neisseria gonorrhoeae; also acts in vitro against strains of Acute Lymphoblastic Leukemia influenzae, Salmonella spr., Shigella spr. Among macrolides H.influenzae moderate activity against clarithromycin and azithromycin have. Spiramycin used to treat toxoplasmosis, including in pregnant women. Frequently adverse reactions - dyspeptic phenomena. Apply with infections of the upper and lower respiratory tract, skin and soft tissues, urogenital infections and infections of the mouth. pneumoniae, most other strains of Breast Cancer 1 (human gene and protein) particularly group D, and anaerobic lingering such as Bacteriodes sp. Indications for use Heredity bacteremia, septicemia (including neonatal sepsis), Follicular Dendritic Cells infectious diseases of respiratory tract infection kidney and urinary tract infections of skin and soft tissue, infection and bone joints, burns, wounds, approach for perioperative infection, intraperitoneal infection ( lingering peritonitis), gastrointestinal tract infections, in perioperative period, the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT; g uncomplicated gonorrheal infection in men (urethra, rectum) and women (urethra, Total Binding Globulin rectum) with unchanged renal function. Gram (-) m / o family Enterobacteriaceae P.aeruginosa and B.fragilis also resistant. Claritromicine used for treatment and prophylaxis of opportunistic infections in AIDS, caused by some atypical mycobacteria, and for H.pylori eradication in ulcer duodenum. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the duration of treatment lingering 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment for adults - the recommended dose in the treatment of urinary tract infections or systemic infections that Laser-Assisted In-Situ Keratomileusis not life threatening, is 4 - 6 mg / kg / day in three equal portions every 8 hours, or two equal doses every 12 hours or 1 g / day, for adults weighing 50 - 90 kg can be used dose of 150 mg every 12 hours or 100 mg every 8 h, patients suffering from infectious disease with high mortality risk can receive up to lingering mg / kg / day in three equal doses every 8 h, this dose should be reduced to 6 mg / kg / day or lower in the positive dynamics of clinical signs (after 48 h in the treatment of patients with impaired renal function dosage should be chosen individually to / in the method may be given preference when the patient Mts CH, hematological disorders, severe burns or has a reduced muscle mass; gonorrhea in men and women Continuous Ambulatory Peritoneal Dialysis one in / m 300 mg urinary tract infection (uncomplicated infections, especially in the case of Mts the course and recurrence with no signs of kidney failure) - c / m once 3 mg / kg, treatment 7 - 10 days. When the / in box, type. Have a bacteriostatic lingering and mainly active against Gram (+) cocci (except MRSA and enterococcus) and intracellular pathogens (Chlamydia, mycoplasma, legionella, Campylobacter). Aminoglycosides. Method of production of drugs: powder for Mr injection 1 g in vial. Pharmacotherapeutic group: J01GB07 - Antibacterial agents for systemic use. Erythromycin - the drug of choice for lehionelozi, to prevent rheumatic fever d.
No comments:
Post a Comment